While adults know how tablets and smartphones can strain the eyes, many parents aren’t warned how these harm their children’s speech development. Researchers recently presented their study at the 2017 Pediatric Academic Societies Meeting in San Francisco, covering how the increased time spent on handheld devices slows speech development in children.

Exsurco® Medical, Inc. announces the launch of a new wound debridement and skin grafting medical device designed for use in burn and trauma centers. Backed by Exsurco’ s knowledge and ground breaking design and innovation, the new Amalgatome® SD is a revolutionary break-through in combining skin grafting and wound debridement technology in an industry that hasn’t seen this kind of innovation for a multiple use device. By using one device for multiple procedures (excision and/or auto grafting), the Amalgatome SD helps those who are in critical need of the healing power of skin.

While tracking apps may be accurate when monitoring steps, researchers warn users of heart rate app that results are not what they appear. In a study, published in the European Journal of Preventive Cardiology, analyzes popular heart rate tracking apps on performance and accuracy.

The Office of the National Coordinator (ONC) have announced a Patient Matching Algorithm Challenge, offering as many as six prizes of $75,000 to find the most accurate tool to eliminate data duplication in electronic medical records (EMRs).

Telemedicine for mental health allows rural patients to receive high quality care—regardless of geographic limitations. A study in Health Affairs investigates "telemental health" by outlining the ins and outs of services offered to rural patients.

Smartphone applications for women to track their menstrual cycles fall short, according to a study that analyzed the current available apps for accuracy in tracking women's varying cycles.

By focusing on beneficiaries with high risks of future spending and steering care away from emergency departments, one participant in the Pioneer ACO model offered a scalable program which can achieve sustainable decreases in care costs, according to a study in the May 2017 issue of Health Affairs.

Researchers examining the recurrence rate of women with high-grade serous ovarian cancer, the most common subtype, have found a combination therapy that could reduce recurrence by 50 percent.